Prestige Consumer Healthcare (PBH) EBT Margin (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted EBT Margin of 21.81% for Q4 2025, down 13.53% on a QoQ basis from 25.22% in Q3 2025, and down 580.0% year-over-year from 4.54% in Q4 2024.
Analysis
Prestige Consumer Healthcare (PBH) EBT Margin (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare has reported EBT Margin for 16 years, with the latest figure at 21.81% in Q4 2025.
- On a quarterly basis, EBT Margin fell 580.0% year-over-year to 21.81% in Q4 2025; TTM through Dec 2025 was 24.16%, a 66.0% decrease from a year earlier, with the FY2025 full-year figure at 24.98%, up 45.0% from the prior year.
- EBT Margin was 21.81% for Q4 2025 at Prestige Consumer Healthcare, down from 25.22% in the prior quarter.
- The five-year high for EBT Margin was 28.37% in Q2 2021, with the low at 104.78% in Q1 2023.
- Average EBT Margin over 5 years is 17.59%, with a median of 24.6% recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: EBT Margin sank 12761 bps in 2023, then surged 12908 bps in 2024.
- Over 5 years, EBT Margin stood at 23.86% in 2021, then rose by 4 bps to 24.72% in 2022, then retreated by 0 bps to 24.61% in 2023, then grew by 12 bps to 27.61% in 2024, then retreated by 21 bps to 21.81% in 2025.
- The last three EBT Margin figures came in at 21.81% (Q4 2025), 25.22% (Q3 2025), and 24.76% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 17.72% |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 15.12% |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 13.65% |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 10.83% |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 10.31% |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | -0.28% |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 3.16% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 604.06 Mn | 498.16 Mn | 40.36 Mn | 12.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 21.81% |
| Sep 30, 2025 | 25.22% |
| Jun 30, 2025 | 24.76% |
| Mar 31, 2025 | 24.94% |
| Dec 31, 2024 | 27.61% |
| Sep 30, 2024 | 25.25% |
| Jun 30, 2024 | 21.87% |
| Mar 31, 2024 | 24.30% |
| Dec 31, 2023 | 24.61% |
| Sep 30, 2023 | 24.59% |
| Jun 30, 2023 | 24.60% |
| Mar 31, 2023 | -104.78% |
| Dec 31, 2022 | 24.72% |
| Sep 30, 2022 | 23.02% |
| Jun 30, 2022 | 25.59% |
| Mar 31, 2022 | 22.84% |
| Dec 31, 2021 | 23.86% |
| Sep 30, 2021 | 21.59% |
| Jun 30, 2021 | 28.37% |
| Mar 31, 2021 | 16.98% |